Philogen
€22.20Change from previous close: −0.45%Absolute change: −€0.10
At a glance
- Revenue growth
- +324.79%
- 2025 vs 2024
- Net income growth
- +407.10%
- 2025 vs 2024
- Net margin
- 73.1%
- 2024: 61.2%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | 268 | 40.8 | -4.8 | -4.9 | — |
| Depreciation and amortization | 4.3 | 3.9 | 3.6 | 2.8 | — |
| Capital expenditure | -3.6 | -2.4 | -5.9 | -4.2 | — |
| Investing cash flow | -168 | -22.3 | 0.2 | 24.2 | — |
| Financing cash flow | -3.0 | -3.8 | -4.2 | -3.8 | — |
| Share repurchases | -1.8 | -0.0 | -2.4 | -1.9 | — |
| Debt issued | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Debt repaid | 0.0 | -2.8 | -0.8 | -1.1 | — |
| Effect of exchange rates | 0.7 | 0.2 | 0.0 | 0.1 | — |
| Net change in cash | 96.6 | 14.8 | -8.8 | 15.5 | — |
| Free cash flow | 264 | 38.4 | -10.7 | -9.2 | — |